Feedback / Questions
CYTO-102 - CytoImmune
CYTO NK-201 - CytoImmune
MB-109 - Fortress
https://www.businesswire.com/news/home/20220408005022/en/City-of-Hope-to-Present-Late-Breaking-and-Clinical-Trial-Data-at-AACR-Cell-Therapy-and-Preventive-Medicine/
Apr 8, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next